Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000899243-20-018817

Chief Scientific Officer sold 2,951 shares at $20.00 ($59,020)

  • Chief Scientific Officer acquired 2,951 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Wallace Owen B. Chief Scientific Officer 2020-07-08 Option exercise +2,951 $7.84 $23,136 130,039 D
Wallace Owen B. Chief Scientific Officer 2020-07-08 Sale −2,951 $20.00 $59,020 127,088 D
Derivatives
Wallace Owen B. Chief Scientific Officer 2020-07-08 Option exercise · Stock Option (right to buy) −2,951 81,942 D
Open-market sales · 2,951 sh · avg $20.00 · $59,020
Loading xslF345X03/doc4.xml…